Select Net Income vs Operating Income Analysis
SEM Stock | USD 21.34 0.50 2.40% |
Select Medical financial indicator trend analysis is much more than just breaking down Select Medical Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Select Medical Holdings is a good investment. Please check the relationship between Select Medical Net Income and its Operating Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Net Income vs Operating Income
Net Income vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Select Medical Holdings Net Income account and Operating Income. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Select Medical's Net Income and Operating Income is 0.96. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Operating Income in the same time period over historical financial statements of Select Medical Holdings, assuming nothing else is changed. The correlation between historical values of Select Medical's Net Income and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Select Medical Holdings are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Net Income i.e., Select Medical's Net Income and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.96 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Select Medical Holdings financial statement analysis. It represents the amount of money remaining after all of Select Medical Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Operating Income
Operating Income is the amount of profit realized from Select Medical Holdings operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Select Medical Holdings is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from Select Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Select Medical Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. As of the 28th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.03, while Selling General Administrative is likely to drop about 119.3 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 136.0M | 169.1M | 198.6M | 152.3M | Depreciation And Amortization | 202.6M | 205.8M | 208.7M | 135.3M |
Select Medical fundamental ratios Correlations
Click cells to compare fundamentals
Select Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Select Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.3B | 7.7B | 7.4B | 7.7B | 7.7B | 4.9B | |
Short Long Term Debt Total | 4.5B | 4.5B | 4.7B | 5.1B | 5.0B | 2.9B | |
Other Current Liab | 535.4M | 799.9M | 748.5M | 656.5M | 728.0M | 365.1M | |
Total Current Liabilities | 914.3M | 1.4B | 1.3B | 1.2B | 1.2B | 713.0M | |
Total Stockholder Equity | 929.0M | 1.1B | 1.3B | 1.3B | 1.3B | 788.0M | |
Property Plant And Equipment Net | 2.0B | 2.0B | 2.0B | 2.2B | 2.2B | 2.3B | |
Net Debt | 4.2B | 3.9B | 4.6B | 5.0B | 4.9B | 2.8B | |
Retained Earnings | 279.8M | 553.2M | 593.3M | 581.0M | 751.9M | 789.4M | |
Accounts Payable | 145.7M | 177.1M | 233.8M | 186.7M | 174.3M | 131.2M | |
Cash | 335.9M | 577.1M | 74.3M | 97.9M | 84.0M | 110.8M | |
Non Current Assets Total | 6.1B | 6.1B | 6.2B | 6.4B | 6.4B | 4.0B | |
Non Currrent Assets Other | 323.9M | 319.2M | 356.7M | 341.7M | 60.7M | 57.7M | |
Cash And Short Term Investments | 335.9M | 577.1M | 74.3M | 97.9M | 143.0M | 115.1M | |
Net Receivables | 762.7M | 896.8M | 889.3M | 941.3M | 940.3M | 597.3M | |
Good Will | 3.4B | 3.4B | 3.4B | 3.5B | 3.5B | 2.5B | |
Common Stock Shares Outstanding | 130.3M | 129.8M | 130.2M | 124.6M | 123.1M | 134.7M | |
Liabilities And Stockholders Equity | 7.3B | 7.7B | 7.4B | 7.9B | 7.7B | 4.9B | |
Non Current Liabilities Total | 5.5B | 5.0B | 4.8B | 5.2B | 4.9B | 3.3B | |
Other Current Assets | 114.4M | 120.2M | 175.8M | 264.0M | 174.3M | 236.7M | |
Other Stockholder Equity | 649.1M | 509.1M | 504.3M | 452.2M | 493.4M | 560.4M | |
Total Liab | 6.4B | 6.4B | 6.0B | 6.3B | 6.1B | 4.1B | |
Property Plant And Equipment Gross | 2.0B | 2.0B | 2.0B | 1.0B | 3.6B | 3.8B | |
Total Current Assets | 1.2B | 1.6B | 1.1B | 1.3B | 1.3B | 829.8M | |
Accumulated Other Comprehensive Income | 0.0 | (2.0M) | 12.3M | 88.6M | 42.9M | 45.1M | |
Short Term Debt | 233.1M | 453.4M | 289.3M | 311.5M | 344.6M | 361.8M | |
Intangible Assets | 409.1M | 387.5M | 374.9M | 351.7M | 329.9M | 233.3M | |
Other Liab | 249.6M | 301.1M | 249.2M | 275.9M | 317.3M | 200.2M | |
Other Assets | 93.2M | 1.4B | 356.7M | 94.3M | 108.5M | 202.7M | |
Long Term Debt | 3.4B | 3.4B | 3.6B | 3.8B | 3.6B | 2.6B | |
Property Plant Equipment | 998.4M | 943.4M | 961.5M | 2.2B | 2.5B | 2.6B | |
Net Tangible Assets | (2.1B) | (2.3B) | (2.7B) | 804.3M | 723.9M | 760.1M | |
Noncontrolling Interest In Consolidated Entity | 158.1M | 192.5M | 215.9M | 234.6M | 269.8M | 283.3M | |
Retained Earnings Total Equity | 279.8M | 553.2M | 593.3M | 581.0M | 668.2M | 401.2M | |
Long Term Debt Total | 3.4B | 3.4B | 3.6B | 3.8B | 4.4B | 2.9B | |
Capital Surpluse | 491.0M | 509.1M | 504.3M | 452.2M | 520.0M | 521.3M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.139 | Dividend Share 0.5 | Earnings Share 2.14 | Revenue Per Share 56.158 | Quarterly Revenue Growth 0.057 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.